Evidence for a viral etiology of multiple sclerosis

Handbook of Multiple Sclerosis, Third Edition

Volumn , Issue , 2001, Pages 115-138

  Cook, Stuart D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1442316672     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (165)

1. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand Suppl 1995; 161:34-42.
2. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1985; 6:382-427.
3. Perron H, Lalande B, Gratacap B, Laurent A, Genoulaz O, Geny C, Mallaret M, Schuller E, Stoebner P, Seigneurin JM. Isolation of retrovirus from patients with multiple sclerosis. Lancet 1991; (337):862-863.
4. Challoner PB, Smith KT, Parker JD, et al. Plaque associated expression of human herpesvirus 6 in multiple sclerosis. Proc natl Acad Sci USA 1995; 92:7440-7444.
5. Sriram S, Stratton CW, Yao S, et al. Chlamydia penumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 46:6-14.
6. Marie P. Sclerose en plaques et maladies infectieuses. Prog Med Paris 1884; 12:287-289, 305-307, 349-351, 365-366.
7. Cook SD. Multiple sclerosis Arch Neurol 1998; 55:421-423.
8. McFarland DE, MacFarland HF. Multiple sclerosis. N Engl J Med 1982; 11:1246-1250.
9. Johnson RT. The virology of demyelinating diseases. Ann Neurol 1994; 36:554-560.
10. Rice GPA. Virus-induced demyelination in man: Models for multiple sclerosis. Curr Opin Neurol Neurosurg 1992; 5:188-194.
11. Raoult D, Birg M, La Scola B, Fournier P. Cultivation of the bacillus of Whipple’s disease. N Engl J Med 2000; 342:620-625.
12. Blaser MJ. Bacteria and diseases of unknown cause. Ann Intern Med 1994; 121:144-145.
13. Kurtzke JF. MS epidemiology worldwide: One view of current status. Acta Neurol Scand Suppl 1995; 161:23-33.
14. Cook SD. Epidemiology of multiple sclerosis: Clues to etiology of a mysterious disease. Neuroscientist 1996; 2:172-180.
15. Alter M, Zhen-win Z, Davanipour Z, et al. Multiple sclerosis and childhood infections. Neurology 1986; 36:1386-1389.
16. Alvord EC, Jahnke U, Fischer EH, et al. The multiple causes of multiple sclerosis: The importance of infections in childhood. J Child Neurol 1987; 2:313-321.
17. Haile R, Smith P, Read D, et al. A study of measles virus and canine distemper virus antibodies and of childhood infections in multiple sclerosis patients and controls. J Neurol Sci 1982; 56:1-10.
18. Sullivan CB, Visscher BR, Detels R. Multiple sclerosis and age of exposure to childhood diseases and animals: Cases and their friends. Neurology 1984; 34:1144-1148.
19. Poskanzer DC, Sheridan JL, Prenny LB, et al. Multiple sclerosis in the Orkney and Shetland Islands: II. The search for an exogenous aetiology. J Epidemiol Commun Health 1980; 34: 240-252.
20. Gronning M, Riise T, Kvale G, et al. Infections in childhood and adolescence in multiple sclerosis. Neuroepidemiology 1993; 12:61-69.
21. Operalski EA, Visscher BR, Malmgren R, Detels R. A case-control study of multiple sclerosis. Neurology 1989; 39:825-829.
22. Sadovnick AD, Armstrong H, Rice GPA, et al. A population based study of multiple sclerosis in twins: Update. Ann Neurol 1993; 33:281-285.
23. Eldridge R, Herndon CN. Multiple sclerosis in twins. N Engl J Med 1987; 318:50.
24. Chu AB, Sever JL, Madden DL, et al. Olilgoclonal IgG bands in cerebrospinal fluid in various neurological diseases. Ann Neurol 1983; 13:434-439.
25. Vartdal F, Vandvik B. Multiple sclerosis: Electrofocused '‘bands’’ of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses. J Neurol Sci 1992; 54:99-107.
26. Norrby E, Link H, Olsson JE, Panelius M, Salmi A, Vandvik B. Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immunol 1974; 10:688-694.
27. Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol 1978; 24:1-39.
28. Vartdal F, Vandvik B, Norrby E. Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol 1979; 8:248-255.
29. Vandvik B, Nilsen RE, Vartdal F, Norrby E. Mumps meningitis: Specific and nonspecific antibody responses in the central nervous system. Acta Neurol Scand 1982; 65:468-487.
30. Gilden DH, Devlin ME, Burgoon MP, Owens GP. The search for virus in multiple sclerosis brain. Mult Scler 1996; 2:179-183.
31. Yao S-Y, Sriram S. Reactivity of oligoclonal bands seen in CSF to C. pneumoniae antigens in patients with multiple sclerosis. Neurology 1999; 52 (suppl 2):A559.
32. Cook SD, Dowling PC, Blumberg BM. Infection and autoimmunity in the Guillain. Barré syndrome. In: JA Aarli, WMH Behan, PO Behan, eds. Clinical Neuroimmunology. London: Blackwell Scientific, 1987, pp. 225-247.
33. Kennedy PGE, Steiner L. On the possible viral aetiology of multiple sclerosis. QJ Med 1994; 87:523-528.
34. Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N Engl J Med 1999; 341:2068-2074.
35. Evans CE, Horowitz MS, Hobbs MV, Oldstone MBA. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996; 184:2371-2384.
36. Rudge P. Does a retrovirally encoded superantigen cause multiple sclerosis? J Neurol Neurosurg Psychiatry 1991; 54:853-855.
37. Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985; 162:583-591.
38. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695-705.
39. Krakowka S, Cockerell G, Koestner A. Effects of canine distemper virus on lymphoid function in vitro and in vivo. Infect Immun 1975; 11:1069-1078.
40. Cerruti-Sola S, Kristensen F, Vandevelde M, Bichsel P, Kihm U. Lymphocyte responsiveness to lectin and myelin antigens in canine distemper infection in relation to the development of demyelinating lesions. J Neuroimmunol 1983; 4:77-90.
41. Dowling PC, Cook SD. Role of infection in Guillain-Barré syndrome: Laboratory confirmation of herpesviruses in 41 cases. Ann Neurol 1981; 9(suppl):44-55.
42. Cook SD, Blumberg BM, Dowling PC. Potential role of paramyxoviruses in multiple sclerosis. In: G Thornton, J Booss, eds. Neurology Clinics: Infectious Diseases of the Nervous System. Philadelphia: Saunders, 1986, pp. 303-319.
43. Boos J, Kim JH. Evidence for a viral etiology of multiple sclerosis. In: Cook SD, ed. Handbook of Multiple Sclerosis. New York: Marcel Dekker, 1990.
44. Adams JM, Imagawa DT. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med 1962; 3:562-566.
45. Jacobson S, Flerlage ML, McFarland HF. Impaired measles virus-specific cytotoxic T cell responses in multiple sclerosis. J Exp Med 1985; 162:839-850.
46. Haase AT, Ventura P, Gibbs CJ Jr, et al. Measles virus neucleotide sequences: detection by hybridization in situ. Science 1981; 212:672-675.
47. Crosby SL, McQuaid S, Taylor JM, et al. Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus. J Gen Virol 1989; 70:2027-2036.
48. Stevens JG, Bastone VB, Ellison GW, Myers LW. No measles virus genetic information detected in multiple sclerosis-derived brains. Ann Neurol 1979; 8:625-627.
49. Dowling PC, Blumberg BM, Kolakofsky D, et al. Measles virus nucleic acid sequences in human brain. Virus Res 1986; 5:97-107.
50. Murray R, Brown B, Brain D, Cabirac G. Detection of corona virus RNA and antigen in MS brain. Ann Neurol 1992; 31:525-533.
51. Fujinami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 1985; 230:1043-1045.
52. Kurtzke JF. Multiple sclerosis-An overview. In: Rose FC, ed. Clinical Neuroepidemiology. London: Pitman Medical, 1980, pp. 170-195.
53. Cook SD, Cromarty JI, Tapp W, Poskanzer D, Walker JD, Dowling PC. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985; 35:545-551.
54. Cook SD, Mac Donald J, Tapp W, Poskanzer D, Dowling PC. Multiple sclerosis in the Shetland Islands: An update. Acta Neurol Scand 1988; 77:148-151.
55. Lauer K. Multiple sclerosis in the old world: The new old map. In: W Firnhaber, L Lauer, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: LTV Press, 1994, pp. 14-27.
56. Bansil S, Troiano R, Dowling PC, Cook SD. Measles vaccination does not prevent multiple sclerosis. Neuroepidemiology 1990; 9:248-254.
57. Ryberg B. Acute measles infection in a case of multiple sclerosis. Acta Neurol Scand 1979; 59:221-224.
58. Fleming JO, Zaatari FAK, Gilmore W, et al. Antigenic assessment of coronaviruses isolated from patients with multiple sclerosis. Arch Neurol 1988; 45:629-633.
59. Stewart JN, Mounir S, Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 1992; 191:502-505.
60. Talbot PJ,É kandé S, Cashman NR, Mounir S, Stewart J. Neurotropism of human coronavirus. In: Laude H, Vautherot JF, eds. Coronaviruses. New York: Plenum Press, 1994.
61. Watanabe R, Wege H, ter Meulen V. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 1983; 305:150-153.
62. Tanaka R, Iwasaki Y, Koprowski H. Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. J Neurol Sci 1976; 28:121-126.
63. Salmi A, Zoila B, Hovi T, Reunanen M. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology 1982; 32:292-295.
64. Sorenson O, Collins A, Flintoff W, et al. Probing for the human coronavirus OC43 in multiple sclerosis. Neurology 1986; 36:1604-1606.
65. Evans AS, Niederman JC. Epstein-Barr virus. In: S Alfred, AS Evans, eds. Viral Infection of Humans: Epidemiology and Control, 3rd ed. New York: Plenum Press, 1989.
66. Henle G, Henle W, Diehl V. Relation of Burkitt tumor associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968; 59:94-101.
67. Paskavitz JF, Anderson CA, Filley CM, Kleinschmidt-DeMasters BK, Tyler KL. Acute arcuate fiber demyelinating encephalopathy following Epstein-Barr virus infection. Ann Neurol 1995; 38:127-131.
68. Bray PF, Culp KW, McFarlin DE, Panitch HS, Torkelson RD, Schlight JP. Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology 1992; 42:278-282.
69. Warner HB, Carp RI. Multiple sclerosis and Epstein-Barr virus. Lancet 1981; 2:1290.
70. Haahr S, Kochenriksen N, Mollerlarsen A, Eriksen LS. Increased risk of multiple sclerosis after late Epstein-Barr virus infection-a historical prospective study. Acta Neurol Scand 1997; 95(suppl 169):70-75.
71. Lindberg C, Andersen O, Vahlne A, Dalton M, Remarker B. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 1991; 10:62-65.
72. Martyn CN, Cruddas M, Compston DAS. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56:167-168.
73. Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD. Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis. Arch Neurol 1983; 40:406-408.
74. Sumaya CV, Myers LW, Ellison GW. Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol 1980; 37:94-96.
75. Larsen PD, Bloomer LC, Bray PF. Epstein-Barr nuclear antigen and virus capsid antigen titers in multiple sclerosis. Neurology 1985; 35:435-438.
76. Bray PF, Luka J, Culp KW, Schlight JP. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992; 42:798-804.
77. van Sechel AC, Bajramovic JJ, van Stipdonk MS, et al. EBV-induced expression and HLADR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis. J Immunol 1999; 162:129-135.
78. Esposito M, Venkatesh V, Otvos L, Weng Z, Vajda S, Banki K, Perl A. Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients. Journal of Immunology 1999; 163:4027-4032.
79. Hilton DA, Love S, Fletcher A, Pringle JH. Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridization. J Neurol Neurosurg Psychiatry 1994; 57:975-976.
80. Koprowski H, DeFreitas EC, Harper ME, et al. Multiple sclerosis and human T-cell lymphotrophic retroviruses. Nature 1985; 318:154-160.
81. Rasmussen HB, Perron H, Clausen J. Do endogenous retroviruses have etiologic implications in inflammatory and degenerative nervous system diseases? Acta Neurol Scand 1993; 88: 190-198.
82. Perron H, Geny C, Laurent A, et al. Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol 1989; 140:551-561.
83. Garson JA, Tuke PW, Giraud P, Paranhos Baccala G, Perron H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis (letter). Lancet 1997; 351: 33.
84. Haahr S, Sommerelund M, Møller-Larsen A, Nielsen R, Hansen HJ. Just another dubious virus in cells from a patient with multiple sclerosis? Lancet 1991; 337:863-864.
85. Perron H, Gaerson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande L, Seigneurin JM, Mandrand B. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc Natl Acad Sci USA 1997; 94:7583-7588.
86. Haahr S, Sommerlund M, Christensen T, Jensen AW, Hansen HA, Møller-Larsen A. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease. Ann N Y Acad Sci 1994; 724:148-152.
87. Fujinami RS, Libbey JE. Endogenous retroviruses: are they the cause of multiple sclerosis? Trends Microbiol 1999; 7(7):263-264.
88. Clerici M, Fusi ML, Caputo D, Guerini FR, Trabattoni D, Salvaggio A, Cazzullo CL, Arienti D, Villa ML, Urnovitz HB, Ferrante P. Immune response to antigens of human endogenous retroviruses in patients with acute or stable multiple sclerosis. J Neuroimmunol 1999; 99: 173-182.
89. Meinl E. Concepts of viral pathogenesis of multiple sclerosis (review). Curr Opin Neurol 1999; 12(3):303-307.
90. Hackett J, Swanson P, Leahy D, Anderson EL, Sato S, Roos RP, Decker R, Devare SG. Search for retrovirus in patients with multiple sclerosis. Ann Neurol 1996; 40:805-809.
91. Brahic M, Bureau JF. Multiple sclerosis and retroviruses (letter). Ann Neurol 1997; 42:984-985.
92. Wilborn F, Schmidt CA, Brinkmann V, Jendroska K, Oettle H, Siegert W. A potential role for human herpes virus type 6 in nervous system disease. J Neuroimmunol 1994; 49:213-214.
93. Sola P, Merelli E, Marasca R, et al. Human herpesvirus 6 and multiple sclerosis: Survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993; 56:917-919.
94. Saito Y, Sharer LR, Dewhurst S, Blumberg BM, Hall CB, Epstein LG. Cellular localization of human herpes virus-6 in the brains of children with AIDS encephalopathy. J Neurovirol 1995; 1:30-39.
95. Asano Y, Yoshikawa T, Kajita Y, Ogura R, Suga S, Yazaki T, Nakashima T, Yamada A, Kurata T. Fatal encephalitis/encephalopathy in primary human herpesvirus-6 infection. Arch Dis Child 1992; 67:1484-1485.
96. Novoa LJ, Nagra RM, Nakawatase T, Edwards-Lee T, Tourtellotte WW, Cornford ME. Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. J Med Virol 1997; 52:301-308.
97. Merelli E, Sola P, Barozzi P, Torelli G. An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection. J Neurol Sci 1996; 137:42-46.
98. Carrigan DR, Harrington D, Knox KK. Subacute leukoencephalitis caused by CNS infection with human herpesvirus-6 manifesting as acute multiple sclerosis. Neurology 1996; 47:145-148.
99. Kamei A, Ichinohe S, Onuma R, Hiraga S, Fujiwara T. Acute disseminated demyelination due to primary human herpesvirus-6 infection. Eur J Pediatr 1997; 156:709-712.
100. Bergström T. Herpesviruses-A rationale for antiviral treatment in multiple sclerosis. Antivir Res 1999; 41:1-19.
101. Mackenzie IRA, Carrigan DR, Wiley CA. Chronic myelopathy associated with human herpesvirus-6. Neurology 1995; 45:2015-2017.
102. Knox KK, Harrington D, Carrigan DR. Active human herpesvirus type 6 infections are present in the central nervous system, lymphoid tissues and peripheral blood of patients with multiple sclerosis. Ann Neurol 1998; 44:485.
103. Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ, Tourtellotte WW. Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch Neurol 1996; 53:125.
104. Gordon L, Mcquaid S, Cosby SL. Detection of herpes simplex virus (types 1 and 2) and human herpesvirus 6 DNA in human brain tissue by polymerase chain reaction. Clin Diagn Virol 1996; 6(1):33-40.
105. Dowling P, Husar W, Menonna J, Donnenfeld H, Cook SD, Sidhu M. Cell death and birth in multiple sclerosis brain. J Neurol Sci 1997; 149:1-11.
106. Ablashi DV, Lapps W, Kaplan M, et al. Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: A preliminary report. Mult Scler 1998; 4:490-496.
107. Soldan SS, Berti R, Salem N, et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 1997; 3:1994-1997.
108. Kim JS, Park JH, Lee KH, Lee KS, Shin WS. Detection of human herpes virus 6 variant a sequence in multiple sclerosis. Neurology 1999; 52(suppl 2):A491.
109. Goldberg SH, Albright AV, Lisak RP, Gonzalez-Scarano F. Polymerase chain reaction analysis of human herpesvirus-6 sequences in the sera and cerebrospinal fluid of patients with multiple sclerosis. J Neuro virology 1999; 5:134-139.
110. Martin C, Enbom M, Soderstrom M, et al. Absence of seven human herpesviruses including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand 1997; 95:280-283.
111. Tenser RB, Hay KA, Hershey, PA. Herpes viruses in leukocytes of multiple sclerosis patients. Neurology 1999; 52(suppl 2):A558.
112. Ongradi J, Rajda C, Maródi CL, Csiszár A, Vécsci L. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J Neurovirol 1999; 5:529-532.
113. Nielsen L, Larsen AM, Munk M, Vestergaard BF. Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis. Acta Neurol Scand 1997; 169(suppl):76-78.
114. Nielsen L, Mollerlarsen A, Munk M, Vestergaard BF. Human herpesvirus-6 immunoglobulin G antibodies in patients with multiple sclerosis. Acta Neurol Scand 1997; 95(suppl 169): 76-78.
115. Fillet AM, Lozeron P, Agut H, et al. HHV-6 and multiple sclerosis (letter). Nature Med 1998; 4:537.
116. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 2000; 47:306-313.
117. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990; 161:618-625.
118. Danville T. Chlamydia. Pediatr Rev 1998; 19:85-91.
119. Shor A, Phillips JI. Chlamydia penumoniae and athlerosclerosis. JAMA 1999; 282:2071-2073.
120. Maass M, Gieffers J. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol Infec Dis 1996; 6:65-70.
121. Balin BJ, Gerard HC, Arking EJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer’s brain. Med Microbiol Immunol 1998; 187:23-42.
122. Nochlin D, Shaw CM, Campbell LA, Kuo CC. Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease. Neurology 1999; 53:1888.
123. Gieffers J, Reusche E, Solbach W, Maass M. Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer’s disease patients (abstr). Clin Microbiol Infect 1999; 5(suppl 3):90.
124. Sriram S, Mitchell W, Stratton C. Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS. Neurology 1998; 50:571-572.
125. Yao SY, Sriram S, Nashville TN. Reactivity of oligoclonal bands seen in CSF to C. pneumoniae antigens in patients with multiple sclerosis. Neurology 1999; 52(suppl 2):A559.
126. Poland SD, Rice GPA. Chlamydia pneumoniae and multiple sclerosis. Neurology 2000; 54(suppl 3):A165.
127. Boman J, Roblin PM, Sundström P, Sandström M, Hammerschlag MR. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Neurology 2000; 54:265.
128. Appel MJG, Gillespie JH. Canine Distemper Virus. Vienna: Springer-Verlag, 1972, pp. 1-153.
129. Collins SD, Wheeler RE, Shannon RD. Occurrence of Whooping Cough, Chickenpox, Mumps, Measles, and German Measles in 200,000 Survey Families in 28 Large Cities. Bethesda, MD: National Institutes of Health, 1943.
130. Maurer KC, Neilsen SW. Neurological disorders in the raccoon in northeastern United States. J Am Vet Med Assoc 1981; 179:1095-1098.
131. Vandevelde M, Higgins RJ, Kristensen B, Kristensen F, Steck A, Kihm U. Demyelination in experimental canine distemper virus infection; immunological, pathologic and immunohistological studies. Acta Neuropathol (Berl) 1982; 56:285-293.
132. Blythe LL, Schmidtz JA, Roelke M, et al. Chronic encephalomyelitis caused by canine distemper virus in a Bengal tiger. J Am Vet Med Assoc 1983; 183:1159-1162.
133. Yoshikawa Y, Ochikubo F, Matsubara Y, et al. Natural infection with canine distemper virus in a Japanese monkey. Vet Microbiol 1989; 20:193-205.
134. Murray K, Selleck P, Hooper P, et al. A morbillivirus that caused fatal disease in horses and humans. Science 1995; 268:94-97.
135. Higgins RJ, Child G, Vandevelde M. Chronic relapsing demyelinating encephalomyelitis associated with persistent canine distemper virus infection. Acta Neuropathol 1989; 77:441-444.
136. Bansil S, Singhal BS, Ahuja GK, et al. Multiple sclerosis in India: A case control study of environmental exposures. Acta Neurol Scand 1997; 95:208-210.
137. Norman J, Cook SD, Dowling PC. Pilot survey of household pets among veterans with multiple sclerosis and age-matched controls. Arch Neurol 1983; 40:213-214.
138. Man, dogs and hydatid disease (editorial). Lancet 1987; 1:21-22.
139. Cook SD, Dowling PC. A possible association between house pets and multiple sclerosis. Lancet 1977; 1:980-982.
140. Cook SD, Natelson BH, Levin BE, et al. Further evidence of a possible association between house dogs and multiple sclerosis. Ann Neurol 1978; 3:141-143.
141. Compston DAS, Vakarelis BN, Paul E, McDonald WI, Batchelor JR, Mims CA. Viral infections in patients with multiple sclerosis and HLA-DR matched controls. Brain 1986; 109: 325-344.
142. Leibowitz U, Alter M. Multiple Sclerosis: Clues to Its Cause. Amsterdam: North-Holland, 1973.
143. Antonovsky A, Leibowitz U, Smith H, et al. Epidemiologic study of multiple sclerosis in Israel, part I (an overall review of methods and findings). Arch Neurol 1965; 13:183-193.
144. Jotkowitz S. Multiple sclerosis and exposure to house pets. JAMA 1977; 238:854.
145. Flodin U, Soderfeldt B, Noorlind-Brage H, Fredriksson M, Axelson O. Multiple sclerosis, solvents and pets: A case-referent study. Arch Neurol 1988; 45:620-623.
146. Landtblom AM, Flodin U, Karlsson M. Multiple sclerosis and exposure to solvents; Ionizing radiation, and animals. Scand J Work Environ Health 1993; 19:399-404.
147. Antonovsky A, Leibowitz U, Medalie JM, et al. Reappraisal of possible aetological factors in multiple sclerosis. Am J Public Health 1968; 58:836-848.
148. Mititelu G, Cernescu C, Bourceanu R. Dog ownership among multiple sclerosis patients and their level of measles antibodies: A case control study. Rev Med Chir Soc Med Nat Iasi 1986; 90:673-677.
149. Granieri E, Casetta I, Tola MR. Epidemiology of multiple sclerosis in Italy and southern Europe. Acta Neurol Scand Suppl 1995; 161:60-70.
150. Anderson LJ, Kibler RF, Kaslow RA, et al. Multiple sclerosis unrelated to dog exposure. Neurology 1984; 34:1149-1154.
151. Warren SA, Warren KG, Greenhill S, Paterson M. How multiple sclerosis is related to animal illness, stress and diabetes. Can Med Assoc J 1982; 126:377-385.
152. Read D, Nassim D, Smith P, Paterson C, Warlow C. Multiple sclerosis and dog ownership: A case-control investigation. J Neurol Sci 1982; 55:359-367.
153. Bauer HJ, Wikstrom J. Multiple sclerosis and house pets. Lancet 1978; 2:1029.
154. Hughes RAC, Russell WC, Froude JRL, Jarrett RJ. Pet ownership, distemper antibodies and multiple sclerosis. J Neurol Sci 1980; 47:429-432.
155. Zurbriggen A, Müller C, Vandevelde M. In situ hybridization of virulent canine distemper virus in brain tissue, using digozigenin-labeled probes. Am J Vet Res 1993; 54:1457-1461.
156. Sidhu SS, Husar W, Cook SD, Dowling PC, Udem SA. Canine distemper terminal and intergenic non-protein coding nucleotide sequences: completion of the entire CDV genome. Virology 1993; 193:66-72.
157. Sidhu SS, Menonna JP, Cook SD, Dowling PC, Udem SA. Canine distemper virus L gene: Sequence and comparison with related viruses. Virology 1993; 193:50-65.
158. Cook SD, Dowling PC, Russell WC. Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis. J Neurol Sci 1979; 41:61-70.
159. Appel MJ, Glickman LI, Raine CS, et al. Viruses and multiple sclerosis. Neurology 1981; 31:944-949.
160. Rohowsky-Kochan C, Dowling PC, Cook SD. Canine distemper virus-specific antibodies in multiple sclerosis. Neurology 1995; 45:1554-1560.
161. Rohowsky-Kochan. Unpublished data.
162. Cook SD, Dowling PC, Prineas JW, et al. A radioimmunoassay search for measles and distemper antigens in subacute sclerosing panencephalitis and multiple sclerosis brain tissues. J Neurol Sci 1981; 51:447-456.
163. Hall WW, Choppin PW. Failure to detect measles virus proteins in brain tissue of patients with multiple sclerosis. Lancet 1982; 1:957.
164. Simini B. Measurement of posterior fossa neurovascular anomalies in essential hypertension (letter). Lancet 1995; 345:131.
165. Bernard C. Introduction à 1' étude de la médecine expérimentale. Paris: Baillière, 1865. [Republished Paris: Garnier-Flammarion, 1966.]